P Lilitkarntakul, N Dhaun, V Melville, S Blackwell… - Atherosclerosis, 2011 - Elsevier Patients with chronic kidney disease (CKD) have increased risk of cardiovascular disease to which co-morbidity and associated conventional risk factors contribute. We hypothesised that arterial stiffness (AS) and endothelial dysfunction (ED), as surrogates of cardiovascular ... All 3 versions
[PDF] from nefrologiavirtual.com.arBL Riser, FC Barreto, R Rezg, PW Valaitis… - Nephrology Dialysis …, 2011 - ERA-EDTA Background. The high rate of cardiovascular mortality in patients with end-stage renal disease (ESRD) is a significant barrier to improved life expectancy. Unique in this population is the marked development and aggressive worsening of vascular calcification (VC). Pyrophosphate ... Related articles - All 3 versions
JG Heaf… - Nephron Clinical Practice, 2011 - content.karger.com Introduction: Chronic kidney disease (CKD) is a progressive disease leading to loss of glomerular filtration rate (ΔGFR, measured in ml/min/1.73 m 2 /year). ΔGFR is usually assumed to be constant, but the hyperfiltration theory suggests that it accelerates in severe uraemia. A ... Related articles - All 2 versions
[PDF] from danmedbul.dkMB Elming, M Hornum, B Feldt-Rasmussen… - Danish medical …, 2011 - danmedbul.dk Patients with end-stage renal disease independent of the presence of diabetes mellitus (DM) often have auto- nomic dysfunction [1]. Some of the earliest signs of autonomic neuropathy are a reduction in heart rate variability, the so-called beat-to-beat variation [2]. Abnormal ... Related articles - View as HTML - All 2 versions
SM Schreier, H Steinkellner, L Jirovetz, M Hermann… - Biochimie, 2011 - Elsevier Carbamoylation is the non-enzymatic reaction of cyanate with amino-, hydroxy- or thiol-groups. In vivo, amino-group modification (N-carbamoylation) resulting in altered function of proteins/amino acids has been observed in patients suffering from uraemia due to urea- ... All 2 versions